hiPS Cell Heterogeneous Tissue via GATA6 Symmetry Break

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating human induced pluripotent stem (hiPS) cells primarily focus on deriving homogenous populations of specialized cells, which have limited success in producing complex, stable tissues, and do not effectively replicate the heterogeneous environments and complex interactions present during embryonic and fetal development.

Innovation Solution

Introducing a 'symmetry break' in hiPS cells by engineering a pulse of expression of a single transcription factor, such as GATA6, to initiate a gastrulation-like event, allowing for the rapid emergence and co-differentiation of all three germ layers, resulting in the formation of complex, heterogeneous tissues under standard cell culture conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If current methods focus on deriving homogenous populations of specialized cells from hiPS cells, then cell specialization is achieved, but the ability to produce complex, stable tissues is limited

Engineering Contradiction:
Improvecell specializationVSAvoidtissue stability
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent applies asymmetry by introducing a single transcription factor (GATA6) to break the symmetry of the homogeneous pluripotent cell population, creating asymmetric differentiation into multiple germ layers (ectoderm, mesoderm, endoderm) and enabling complex tissue formation with stable cell type ratios

Inventive Principle:
Principle #4Asymmetry

2Ease of manufacture

If homogenous cell populations are used for tissue generation, then derivation process is simplified, but complex tissue formation fails to replicate embryonic development

Engineering Contradiction:
Improvederivation processVSAvoidtissue complexity
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The patent changes the key parameter of cell population heterogeneity by engineering hiPS cells to express GATA6, transforming the cell population from homogeneous to heterogeneous with multiple cell types co-differentiating in defined ratios that replicate embryonic development

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If multiple transcription factors are engineered to produce heterogeneous tissues, then tissue complexity increases, but process complexity and external interference increase

Engineering Contradiction:
Improvetissue heterogeneityVSAvoidengineering process
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent segments the complex process of generating heterogeneous tissues by using a single transcription factor (GATA6) that autonomously orchestrates the formation of multiple germ layers and cell types, eliminating the need for complex multi-factor engineering protocols

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The engineered GATA6 expression enables the cell population to self-organize into heterogeneous tissues with proper cell type ratios and spatial organization, reducing external interference and manual protocol complexity

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS10435710B2Engineering a heterogeneous tissue from pluripotent stem cells
Publication Date: 2019.10.08 MASSACHUSETTS INST OF TECH
  • US10435710B2 patent drawing
  • US10435710B2 patent drawing
  • US10435710B2 patent drawing

AI summary

Aspects of the present disclosure are directed to methods and compositions for the production of heterogeneous tissue from human induced pluripotent stem (hiPS) cells.